A detailed history of Close Asset Management LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Close Asset Management LTD holds 5,003 shares of ABBV stock, worth $859,165. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,003
Previous 5,003 -0.0%
Holding current value
$859,165
Previous $857,000 15.29%
% of portfolio
0.03%
Previous 0.03%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$154.79 - $180.76 $9,287 - $10,845
60 Added 1.21%
5,003 $857,000
Q4 2023

Feb 08, 2024

SELL
$137.6 - $154.97 $30,960 - $34,868
-225 Reduced 4.35%
4,943 $766,000
Q3 2023

Oct 11, 2023

BUY
$133.59 - $154.65 $3,339 - $3,866
25 Added 0.49%
5,168 $771,000
Q2 2023

Jul 26, 2023

BUY
$132.51 - $164.9 $29,549 - $36,772
223 Added 4.53%
5,143 $693,000
Q1 2023

Apr 19, 2023

SELL
$144.61 - $166.54 $33,260 - $38,304
-230 Reduced 4.47%
4,920 $784,000
Q2 2022

Jul 29, 2022

SELL
$137.62 - $174.96 $6,881 - $8,748
-50 Reduced 0.96%
5,150 $790,000
Q4 2021

Jan 27, 2022

SELL
$107.43 - $135.93 $16,114 - $20,389
-150 Reduced 2.8%
5,200 $704,000
Q2 2019

Aug 01, 2019

BUY
$65.7 - $83.98 $9,855 - $12,597
150 Added 2.88%
5,350 $389,000
Q1 2019

May 10, 2019

BUY
$77.14 - $90.79 $124,889 - $146,989
1,619 Added 45.21%
5,200 $419,000
Q4 2018

Jan 28, 2019

SELL
$77.85 - $96.01 $164,964 - $203,445
-2,119 Reduced 37.18%
3,581 $267,000
Q3 2018

Nov 09, 2018

BUY
$88.91 - $98.84 $382,313 - $425,012
4,300 Added 307.14%
5,700 $539,000
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $13,434 - $14,731
-150 Reduced 9.68%
1,400 $136,000
Q3 2017

Feb 13, 2018

BUY
$69.85 - $89.22 $108,267 - $138,291
1,550 New
1,550 $0
Q3 2017

Nov 14, 2017

SELL
$69.85 - $89.22 $108,267 - $138,291
-1,550 Closed
0 $0
Q2 2017

Feb 13, 2018

BUY
N/A
1,550 New
1,550 $112,000
Q2 2017

Nov 14, 2017

SELL
N/A
-1,550 Closed
0 $0
Q1 2017

Feb 13, 2018

BUY
N/A
1,550
1,550 $101,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Close Asset Management LTD Portfolio

Follow Close Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Close Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Close Asset Management LTD with notifications on news.